Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 11/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11981452 | 0.88 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL5755910 | 0.88 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL5084510 | 0.88 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL210065 | 0.88 | CYP1A2 (0.67) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL31310689 | 0.88 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL31047535 | 0.88 | MEN1 (0.54) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL807738 | 0.88 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL106639 | 0.88 | MEN1 (0.54) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| SCHEMBL21423998 | 0.88 | BPTF (0.62) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 | |
| Hydrochloric Acid SCHEMBL5755527 | 0.86 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2HTTCNR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1266651-B1 | UV absorbing and photostabilizing agents and compositions and external preparation for skin | SHISEIDO CO LTD (JP) | 2006-09-06 | — | — | EP | claimed |
| EP-1266651-B1 | UV absorbing and photostabilizing agents and compositions and external preparation for skin | SHISEIDO CO LTD (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-6676932-B2 | CONTAINING PYRIDAZINE DERIVATIVE SUNSCREEN AGENT | SHISEIDO CO., LTD. (JP) | 2004-01-13 | — | — | US | disclosed |
| US-20030198608-A1 | Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external prepraration for skin | SHISEIDO CO., LTD. (JP) | 2003-10-23 | — | — | US | disclosed |
| EP-1266651-A2 | UV absorbing and photostabilizing agents and compositions and external preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 2002-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198608-A1 | Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external prepraration for skin | SUN2, UPF1, RRM1 | ALDH1A1 2169/4885SMN1; SMN2 2115/4885HTT 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.